Oxford vaccine trial paused over side effects

September 09, 2020

AstraZeneca maintains that the exact nature of the illness is currently unknown and such pauses are common during the development of a vaccine.

AstraZeneca maintains that the exact nature of the illness is currently unknown and such pauses are common during the development of a vaccine.